1Fleming DF,McQuillan GM,Johnson RE,et al.Herpes simplex virus type 2 in the United States,1976 to 1994[J].N Engl J Med,1997,337(16):1 105～1 111.
2Smith JS,Herrero R,Munoz N,et al.Prevalence and risk factors for herpres simplex virus type 2 infection among middle-age women in Brazil and the Philippines [J].Sex Trasm Dis,2001,28(4):187 ～194.
3Lazcano-Ponce E,Smith JS,Munoz N,et al.High prevalence of antibodies to herpes simplex virus type 2 among middle-aged women in Mexico city,Mexico:a population-based study[J].Sex Transm Dis,2001,28(5):270～276.
6O' Farrell N.Increasing prevalence of genital herpes in developing countries:implications for heterosexual HIV transmission and STI control programmes[J].Sex Transm Infect,1999,75(6):377～384.
7Chen CY,Ballard RC,Beck- Sague CM,et al.Human inmunodeficiency virus infection and genital ulcer disease in South Africa:the herpetie connection[J].Sex Transm Dis,2000,27(1):21～29.
8Fleming DF,Wasserheit JN.From epidemiological synergy to public health policy and practice:the contribution of other sexually transmitted disease to sexual transmisson of HIV infection[J].Sex Transm Infect,1999,75 (1):3～17.
3[1]Institute of Medicine, The hidden epidemic. First edition, Washington DC, National Academy Press, 1997:1～54
4[2]Fathalla M, Diczfalusy E, Spieler J. Contraception 21 - The Promise of Public/Private Sector Collaboration. Intern. J. Gynecol. Obstet,1999.67(Suppl. 2): 1～160
5[3]Ogra PL, Meslecky J, Lamm ME, et al, Mucosal Immunology, 2nd edition, San Diego, Academic Press, 1999. 1～1628
6[4]Documents of Microbicides. 2000. 3 : 13～16
7Benedetti J, Corey L, Ashley R. Recurrence rates in genital herpes after symptomatic first-episode infection. Ann Intern Med, 1994,121(11):847-854.
8Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med, 1997, 337(16) :1105 - 1111.
9Corey L. The current trend in genital herpes. Progress in prevention.Sex Transm Dis, 1994, 21(2 Suppl) :S38 -S44.
10Wald A, Corey L, Cone R,et al. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest, 1997, 99(5) :1092 - 1097.
